Does it really matter WHY it failed? It FAILED! And if the reason was length of time worn or where it was placed, who's fault is that? Wasn't this tested 'in house'? Sending a product for trial for getting FDA clearance should be important enough that your preparation covered all bases. Not enough subjects? How long to wear? All important pretrial in house tests prior to applying for FDA CLEARANCE, NO?
But this was not the first of their product FDA trial failures by this family leadership, as ALLAY failed FDA trials also.
But again, is this really a worry for stockholders? Because as of now, with the USA FDA CLEARANCE they have for all muscle and joint pain, which includes the number ONE human pain - BACK PAIN, they still cannot sell enough product to show, not one year, of profitability. Nope, NOT even close. So would that 'thumb pain' do the trick?
Well on to the next trial --- because this leadership seems much more concerned at doing trials than selling product. Have you SEEN and READ those financial statements? --------- OUCH!
Market Data 
Markets 
AI
